Sun.Aug 11, 2024

article thumbnail

Long-distance relationship revealed in the seemingly random behavior of bowhead whales

Science Daily: Pharmacology News

Applying chaos theory to the movement of iconic arctic whales uncovered a 24-hour diving cycle and a long-range (~100 km) synchronization.

111
111
article thumbnail

How Excessive Heat Can Affect Your Mental Health

Drugs.com

SUNDAY, Aug. 11, 2024 -- As Americans sweat through another scorching summer, one expert warns that while extreme heat can cause physical harm it can also wreak havoc with your mental health.Sizzling temperatures can make anyone irritable, but it.

104
104
article thumbnail

It’s a Cruel Summer – Two New OPDP Untitled Letters

FDA Law Blog: Biosimilars

By Sarah Wicks & Dara Katcher Levy — FDA’s Office of Prescription Drug Promotion (OPDP) has issued two new Untitled Letters this summer after 5 months without any letter activity. The letters are vastly different from one another in subject matter, but together they make a cruel summer of OPDP enforcement against industry. [Editorial note – the Gen X’er included that link first – for the arguably more popular reference, read on.

FDA 57
article thumbnail

Which pharmaceutical companies have the most drug patents in Malaysia?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Malaysia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

Drugs 52
article thumbnail

New patent expiration for Takeda Pharms drug NINLARO

Drug Patent Watch

Annual Drug Patent Expirations for NINLARO Ninlaro is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.

Drugs 52